Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 2, 2019Molecular Therapy — Nucleic AcidsOpen Access

Suppression of Choroidal Neovascularization by AAV-Based Dual-Acting Antiangiogenic Gene Therapy

View Full Paper
Ask AI
Bookmark
Share

Authors

AAAnne Louise AskouSASidsel AlsingJBJosephine Natalia Esther Benckendorff

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Askou et al. (2019) studied this question.

synapsesocial.com/papers/6a89d15a6fc170cbc2fbc54fhttps://doi.org/10.1016/j.omtn.2019.01.012
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Serotype-dependent packaging of large genes in adeno-associated viral vectors results in effective gene delivery in mice2008 · 283 citations
  2. 2Oversized AAV Transductifon Is Mediated via a DNA-PKcs-independent, Rad51C-dependent Repair Pathway2013 · 63 citations
  3. 3A Systematic Review of the Treat and Extend Treatment Regimen with Anti-VEGF Agents for Neovascular Age-Related Macular Degeneration2017 · 52 citations
  4. 4Emerging Issues in AAV-Mediated In Vivo Gene Therapy2017 · 893 citations
  5. 5Characterization of Genome Integrity for Oversized Recombinant AAV Vector2009 · 225 citations